Rapport Therapeutics RAPP
NASDAQ RAPP
$26.53 +1.47 (+5.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rapport Therapeutics (RAPP) Other non-cash items (2023 - 2026)

Updated

Analysis

Rapport Therapeutics (RAPP) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Rapport Therapeutics 1.27 Bn 449.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 595,000.00
Mar 31, 2026 582,000.00
Dec 31, 2025 571,000.00
Sep 30, 2025 567,000.00
Jun 30, 2025 483,000.00
Mar 31, 2025 411,000.00
Dec 31, 2024 165,000.00
Sep 30, 2024 162,000.00
Jun 30, 2024 159,000.00
Mar 31, 2024 7.55 Mn
Dec 31, 2023 254,000.00
Sep 30, 2023 52,000.00
API Access

Rapport Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=RAPP&period=max&api_key=YOUR_API_KEY